GSK reports discovery of MRGPRX2 antagonists for mast cell diseases
Sep. 1, 2022
Mas-related G-protein coupled receptor X2 (MRGPRX2) is expressed particularly on mast cells and its activation leads to the mast cell degranulation with release of inflammatory mediators.